Spots Global Cancer Trial Database for Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
Official Title: Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? A Clinical, Prospective, Randomized, Blinded Examination of Patients Suffering From Hematological Malignancies Treated With Intensive Chemotherapy and/or Radiotherapy.
Study ID: NCT00892502
Study Description
Brief Summary: The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Haematology L, Herlev Hospital, Herlev Ringvej 75, Herlev, , Denmark
Contact Details
Name: Per B Hansen, MD
Affiliation: Department of Haematology, Copenhagen University Hospital at Herlev
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
